328 related articles for article (PubMed ID: 11907489)
1. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
[TBL] [Abstract][Full Text] [Related]
2. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
[TBL] [Abstract][Full Text] [Related]
3. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
Nimkulrat P; Leenutaphong V; Sudtim S
J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
[TBL] [Abstract][Full Text] [Related]
4. Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.
Grundmann-Kollmann M; Podda M; Bräutigam L; Hardt-Weinelt K; Ludwig RJ; Geisslinger G; Kaufmann R; Tegeder I
Br J Clin Pharmacol; 2002 Nov; 54(5):535-9. PubMed ID: 12445034
[TBL] [Abstract][Full Text] [Related]
5. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
[TBL] [Abstract][Full Text] [Related]
6. Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration.
Tegeder I; Muth-Selbach U; Lötsch J; Rüsing G; Oelkers R; Brune K; Meller S; Kelm GR; Sörgel F; Geisslinger G
Clin Pharmacol Ther; 1999 Apr; 65(4):357-68. PubMed ID: 10223771
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of plaque-type psoriasis with cream-PUVA therapy].
Steinmeyer K; Grundmann-Kollmann M; Podda M; Kaufmann R
Hautarzt; 2001 Oct; 52(10):885-7. PubMed ID: 17690819
[TBL] [Abstract][Full Text] [Related]
9. The optimal time to determine the minimal phototoxic dose in skin photosensitized by topical 8 methoxypsoralen.
Man I; Dawe RS; Ferguson J; Ibbotson SH
Br J Dermatol; 2004 Jul; 151(1):179-82. PubMed ID: 15270888
[TBL] [Abstract][Full Text] [Related]
10. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration.
Zucchi A; Raho E; Marconi B; Nicoli S; Santini M; Allegra F; Colombo P; Bettini R; Santi P
J Invest Dermatol; 2001 Aug; 117(2):379-82. PubMed ID: 11511320
[TBL] [Abstract][Full Text] [Related]
11. 8-Methoxypsoralen plasma levels and phototoxic effect.
De Bersaques J; Monbaliu J; Belpaire F; Bogaert M
Photodermatol; 1984 Apr; 1(2):79-84. PubMed ID: 6531285
[TBL] [Abstract][Full Text] [Related]
12. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
[TBL] [Abstract][Full Text] [Related]
13. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
14. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema.
Tzaneva S; Kittler H; Thallinger C; Hönigsmann H; Tanew A
Photodermatol Photoimmunol Photomed; 2009 Apr; 25(2):101-5. PubMed ID: 19292787
[TBL] [Abstract][Full Text] [Related]
15. PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective study.
Schiener R; Gottlöber P; Müller B; Williams S; Pillekamp H; Peter RU; Kerscher M
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):62-7. PubMed ID: 15752122
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of a new oral methoxsalen formulation. A serum concentration and photosensitivity response study.
Sullivan TJ; Walter JL; Kouba RF; Maiwald DC
Arch Dermatol; 1986 Jul; 122(7):768-71. PubMed ID: 3729509
[TBL] [Abstract][Full Text] [Related]
18. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
Lowe NJ; Weingarten D; Bourget T; Moy LS
J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
Engin B; Oguz O
Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of PUVA bath phototoxicity.
Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]